Comprehensive safety analysis of adverse events associated with eptinezumab in migraine treatment
Abstract Migraine significantly impacts quality of life, with eptinezumab emerging as a promising calcitonin gene-related peptide-targeting therapy. Real-world data and clinical trials are crucial for evaluating its safety and effectiveness comprehensively. This study evaluated its safety using a du...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Portfolio
2025-07-01
|
| シリーズ: | Scientific Reports |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1038/s41598-025-09490-1 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|